Patent · US Active

Methods for directed differentiation of pluripotent stem cells to immune cells

US10947502B2 · kind B2 · utility

2Cited by
21References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 2016
Grant dateMar 16, 2021
Priority date
Expiry dateOct 20, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for the efficient in vitro differentiation of somatic cell-derived pluripotent stem cells to hematopoietic precursor cells, and the further differentiation of the hematopoietic precursor cells into immune cells of various myeloid or lymphoid lineages, particularly T cells, NK cells, and dendritic cells. The pluripotent cells may be maintained and differentiated under defined conditions; thus, the use of mouse feeder cells or serum is not required in certain embodiments for the differentiation of the hematopoietic precursor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.